Senior Consultant - Diagnostics & Reporting Lead at Eli Lilly and Company

Bengaluru, Karnataka, India

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

NoVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Experience with statistical analyses such as regression, ANOVA, A/B testing
Proficiency in data analysis using datasets like field execution, tool activity, sales, surveys
Skills in creating and managing Tableau and Power BI reports
Ability to create models such as customer behavior profiles
Knowledge of KPIs, performance tracking, and diagnostics frameworks
Experience with AI and Gen AI agents (implied from responsibilities)

Responsibilities

Collate information regarding the Dynamic targeting diagnostic framework and purposes of analysis
Conduct analysis and draw insights on acceptance and execution of dynamic targeting suggestions
Establish KPIs to measure adoption and usage of new digital offerings or engagement models
Brainstorm performance tracking measures to check if new capabilities/offerings achieve intended goals
Leverage statistical analyses (regression, ANOVA, A/B testing) to track KPIs, draw insights, and suggest course corrections
Use datasets (field execution, tool activity, sales, surveys) to track and tweak deployed field engagement platforms
Validate data quality and accuracy of existing processes
Create models such as customer behavior profiles to support sales teams in enhancing and tracking field force performance
Set up recurring Tableau and Power BI reports to measure key KPIs of field force execution
Create and use AI and Gen AI agents to track performance

Skills

Diagnostics

Reporting

Sales Operations

Data Analysis

Consulting

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free